An inhibitory effect on the production of hepatic TNF-α and IL-6, which take the critical place in carcinogenesis [45], may shed light on the mechanisms of HFD treatment that delays the DEN-induced HCC in its early stage. The gene discussed is TNF; the disease is hepatocellular carcinoma.